Palatin stock climbs 8% on Phase 3 testing update for PL964308/29/2024 (*3*) Palatin stock climbs 8% on Phase 3 testing update for PL9643 [ad_2] Source: Seekingalpha
GSK stock climbs on Delaware court ruling in Zantac case08/28/2024 [ad_1] GSK stock climbs on Delaware court ruling in Zantac case [ad_2] Source: Seekingalpha
